Verve Therapeutics Statistics
Total Valuation
VERV has a market cap or net worth of $994.14 million. The enterprise value is $565.70 million.
| Market Cap | 994.14M |
| Enterprise Value | 565.70M |
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VERV has 89.32 million shares outstanding. The number of shares has increased by 23.92% in one year.
| Current Share Class | 89.32M |
| Shares Outstanding | 89.32M |
| Shares Change (YoY) | +23.92% |
| Shares Change (QoQ) | +2.21% |
| Owned by Insiders (%) | 5.12% |
| Owned by Institutions (%) | 72.21% |
| Float | 65.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.08 |
| Forward PS | 45.75 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.84, with a Debt / Equity ratio of 0.14.
| Current Ratio | 9.84 |
| Quick Ratio | 9.59 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.26% and return on invested capital (ROIC) is -21.73%.
| Return on Equity (ROE) | -34.26% |
| Return on Assets (ROA) | -19.35% |
| Return on Invested Capital (ROIC) | -21.73% |
| Return on Capital Employed (ROCE) | -37.08% |
| Revenue Per Employee | $217,566 |
| Profits Per Employee | -$660,606 |
| Employee Count | 274 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VERV has paid $322,000 in taxes.
| Income Tax | 322,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.55% in the last 52 weeks. The beta is 2.24, so VERV's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | +44.55% |
| 50-Day Moving Average | 8.21 |
| 200-Day Moving Average | 6.45 |
| Relative Strength Index (RSI) | 76.26 |
| Average Volume (20 Days) | 4,353,594 |
Short Selling Information
The latest short interest is 3.63 million, so 4.06% of the outstanding shares have been sold short.
| Short Interest | 3.63M |
| Short Previous Month | 9.89M |
| Short % of Shares Out | 4.06% |
| Short % of Float | 5.54% |
| Short Ratio (days to cover) | 0.46 |
Income Statement
In the last 12 months, VERV had revenue of $59.61 million and -$181.01 million in losses. Loss per share was -$2.10.
| Revenue | 59.61M |
| Gross Profit | -150.82M |
| Operating Income | -208.45M |
| Pretax Income | -192.38M |
| Net Income | -181.01M |
| EBITDA | -201.62M |
| EBIT | -208.45M |
| Loss Per Share | -$2.10 |
Balance Sheet
The company has $497.08 million in cash and $68.64 million in debt, giving a net cash position of $428.44 million or $4.80 per share.
| Cash & Cash Equivalents | 497.08M |
| Total Debt | 68.64M |
| Net Cash | 428.44M |
| Net Cash Per Share | $4.80 |
| Equity (Book Value) | 473.51M |
| Book Value Per Share | 5.33 |
| Working Capital | 459.67M |
Cash Flow
In the last 12 months, operating cash flow was -$142.46 million and capital expenditures -$4.53 million, giving a free cash flow of -$146.98 million.
| Operating Cash Flow | -142.46M |
| Capital Expenditures | -4.53M |
| Free Cash Flow | -146.98M |
| FCF Per Share | -$1.65 |
Margins
| Gross Margin | -252.99% |
| Operating Margin | -349.68% |
| Pretax Margin | -303.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.92% |
| Shareholder Yield | -23.92% |
| Earnings Yield | -18.21% |
| FCF Yield | -14.78% |
Analyst Forecast
The average price target for VERV is $14.57, which is 30.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.57 |
| Price Target Difference | 30.91% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | -4.74% |
| EPS Growth Forecast (5Y) | 6.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VERV has an Altman Z-Score of 0.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.31 |
| Piotroski F-Score | 3 |